O'Sullivan GC - Search Results

1

Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation.

Whelan MC, Casey G, MacConmara M, Lederer JA, Soden D, Collins JK, Tangney M, O'Sullivan GC. Whelan MC, et al. Cancer Gene Ther. 2010 Jul;17(7):501-11. doi: 10.1038/cgt.2010.8. Epub 2010 Feb 26. Cancer Gene Ther. 2010. PMID: 20186173

2

Viral vectors in cancer immunotherapy: which vector for which strategy?

Collins SA, Guinn BA, Harrison PT, Scallan MF, O'Sullivan GC, Tangney M. Collins SA, et al. Curr Gene Ther. 2008 Apr;8(2):66-78. doi: 10.2174/156652308784049345. Curr Gene Ther. 2008. PMID: 18393828 Review.

3

Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.

Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC. Ahmad S, et al. Mol Ther. 2009 Jun;17(6):1101-8. doi: 10.1038/mt.2009.66. Epub 2009 Mar 31. Mol Ther. 2009. PMID: 19337234 Free PMC article.

4

Sonoporation mediated immunogene therapy of solid tumors.

Casey G, Cashman JP, Morrissey D, Whelan MC, Larkin JO, Soden DM, Tangney M, O'Sullivan GC. Casey G, et al. Ultrasound Med Biol. 2010 Mar;36(3):430-40. doi: 10.1016/j.ultrasmedbio.2009.11.005. Epub 2010 Feb 4. Ultrasound Med Biol. 2010. PMID: 20133039

5

Tumour targeting with systemically administered bacteria.

Morrissey D, O'Sullivan GC, Tangney M. Morrissey D, et al. Curr Gene Ther. 2010 Feb;10(1):3-14. doi: 10.2174/156652310790945575. Curr Gene Ther. 2010. PMID: 20156191 Review.

6

Targeting regulatory T cells in cancer.

Byrne WL, Mills KH, Lederer JA, O'Sullivan GC. Byrne WL, et al. Cancer Res. 2011 Nov 15;71(22):6915-20. doi: 10.1158/0008-5472.CAN-11-1156. Epub 2011 Nov 8. Cancer Res. 2011. PMID: 22068034 Free PMC article. Review.

7

Oral tolerance to cancer can be abrogated by T regulatory cell inhibition.

Whelan MC, Casey G, Larkin JO, Guinn BA, O'Sullivan GC, Tangney M. Whelan MC, et al. Among authors: o sullivan gc. PLoS One. 2014 May 15;9(5):e97602. doi: 10.1371/journal.pone.0097602. eCollection 2014. PLoS One. 2014. PMID: 24832130 Free PMC article.

8

Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease.

Tangney M, Casey G, Larkin JO, Collins CG, Soden D, Cashman J, Whelan MC, O'Sullivan GC. Tangney M, et al. Cancer Immunol Immunother. 2006 Nov;55(11):1443-50. doi: 10.1007/s00262-006-0169-z. Epub 2006 Apr 13. Cancer Immunol Immunother. 2006. PMID: 16612593 Free PMC article. Review.

9

Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors.

Collins CG, Tangney M, Larkin JO, Casey G, Whelan MC, Cashman J, Murphy J, Soden D, Vejda S, McKenna S, Kiely B, Collins JK, Barrett J, Aarons S, O'Sullivan GC. Collins CG, et al. Cancer Gene Ther. 2006 Dec;13(12):1061-71. doi: 10.1038/sj.cgt.7700976. Epub 2006 Jul 28. Cancer Gene Ther. 2006. PMID: 16874363

10

Immune gene therapy as a neoadjuvant to surgical excision to control metastatic cancers.

Cashman JP, Larkin JO, Casey G, Whelan MC, Collins C, Aarons S, Tangney M, O'Sullivan GC. Cashman JP, et al. Cancer Lett. 2008 Apr 8;262(1):94-102. doi: 10.1016/j.canlet.2007.11.042. Epub 2008 Jan 7. Cancer Lett. 2008. PMID: 18179863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters